Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nichols

Showing results (391-400 of 842) with videos related to

Pageof 85
Sort By:
Antimicrobial Agents and Chemotherapy|April 1, 1988
Inhibition of tobramycin diffusion by binding to alginateW W Nichols, S M Dorrington, M P Slack, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2022
The primary pharmacology of ceftazidime/avibactam: in vitro translational biologyWright W Nichols, Patricia A Bradford, Sushmita D Lahiri, et al.
Journal of Cardiovascular Pharmacology|August 1, 1991
Combined thrombolytic effects of tissue-plasminogen activator and a fibrinogen-degradation product peptide 6A or iloprostW W Nichols, F A Nicolini, T G Saldeen, et al.
Progress in Clinical and Biological Research|January 1, 1988
Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factorJ Davidson, A Buckley, S Woodward, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
In vivo efficacy of humanized exposures of Ceftazidime-Avibactam in comparison with Ceftazidime against contemporary Enterobacteriaceae isolatesShawn H MacVane, Jared L Crandon, Wright W Nichols, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Efficacies of ceftazidime-avibactam and ceftazidime against Pseudomonas aeruginosa in a murine lung infection modelSeth T Housman, Jared L Crandon, Wright W Nichols, et al.
Angiology|March 1, 1989
Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonistW W Nichols, J Mehta, T J Wargovich, et al.
Artery Research|June 5, 2018
Application of Arterial Hemodynamics to Clinical Practice: A Testament to Medical Science in LondonMichael O'Rourke, Audrey Adji, Wilmer W Nichols, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2019
Electrocatalytic reduction of dioxygen by Mn(iii) meso-tetra(N-methylpyridinium-4-yl)porphyrin in universal bufferLauren E Lieske, Shelby L Hooe, Asa W Nichols, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Effects of phosphorus depletion on left ventricular energy generationT J Fuller, W W Nichols, B J Brenner, et al.
Pageof 85

Showing results (391-400 of 842) with videos related to

Sort By:
Pageof 85
Antimicrobial Agents and Chemotherapy|April 1, 1988
Inhibition of tobramycin diffusion by binding to alginateW W Nichols, S M Dorrington, M P Slack, et al.
The Journal of Antimicrobial Chemotherapy|June 6, 2022
The primary pharmacology of ceftazidime/avibactam: in vitro translational biologyWright W Nichols, Patricia A Bradford, Sushmita D Lahiri, et al.
Journal of Cardiovascular Pharmacology|August 1, 1991
Combined thrombolytic effects of tissue-plasminogen activator and a fibrinogen-degradation product peptide 6A or iloprostW W Nichols, F A Nicolini, T G Saldeen, et al.
Progress in Clinical and Biological Research|January 1, 1988
Mechanisms of accelerated wound repair using epidermal growth factor and basic fibroblast growth factorJ Davidson, A Buckley, S Woodward, et al.
Antimicrobial Agents and Chemotherapy|September 17, 2014
In vivo efficacy of humanized exposures of Ceftazidime-Avibactam in comparison with Ceftazidime against contemporary Enterobacteriaceae isolatesShawn H MacVane, Jared L Crandon, Wright W Nichols, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2013
Efficacies of ceftazidime-avibactam and ceftazidime against Pseudomonas aeruginosa in a murine lung infection modelSeth T Housman, Jared L Crandon, Wright W Nichols, et al.
Angiology|March 1, 1989
Reduced myocardial neutrophil accumulation and infarct size following thromboxane synthetase inhibitor or receptor antagonistW W Nichols, J Mehta, T J Wargovich, et al.
Artery Research|June 5, 2018
Application of Arterial Hemodynamics to Clinical Practice: A Testament to Medical Science in LondonMichael O'Rourke, Audrey Adji, Wilmer W Nichols, et al.
Dalton Transactions (Cambridge, England : 2003)|May 23, 2019
Electrocatalytic reduction of dioxygen by Mn(iii) meso-tetra(N-methylpyridinium-4-yl)porphyrin in universal bufferLauren E Lieske, Shelby L Hooe, Asa W Nichols, et al.
Advances in Experimental Medicine and Biology|January 1, 1978
Effects of phosphorus depletion on left ventricular energy generationT J Fuller, W W Nichols, B J Brenner, et al.
Pageof 85